Integer (ITGR) Holdings will exhibit during MD&M West 2026 in Anaheim, Calif., Feb. 3 – 5. Integer’s integrated R&D ecosystem connecting design, prototyping and manufacturing to help medical device companies develop products that are manufacturable from the start, accelerating the time between design and manufacturability. “Whether you’re advancing structural heart delivery systems, neurovascular catheters, electrophysiology tools, peripheral vascular therapies, or cardiac rhythm management and neuromodulation devices, Integer helps customers design products right the first time – with production in mind,” said Andrew Senn, President, Cardio & Vascular. “Through expert engineers, advanced labs, rapid prototyping, development and scalable manufacturing under one ecosystem, Integer R&D Velocity helps medical device companies bridge the gap between early concepts and real-world production, reducing iterations and expediting development cycles.”
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ITGR:
- Investors Sue Integer (ITGR) Over Heart Device Claims
- Integer Holdings Lawsuit Exposes Adoption Risk in Medical Device Manufacturing Sector
- Raymond James says sale ‘not the only way’ to recognize Integer value
- Integer jumps after WSJ says activist Irenic pushing for sale
- Integer price target raised to $95 from $86 at Truist
